Engineering of a bacterial outer membrane vesicle to a nano-scale reactor for the biodegradation of β-lactam antibiotics

Ji Min Woo, Myeong Yeon Kim, Ji Won Song, Yoonjin Baeg, Hye Jin Jo, Sun Shin Cha, Jin Byung Park

Research output: Contribution to journalArticlepeer-review

Abstract

Bacterial outer membrane vesicles (OMVs) are small unilamellar proteoliposomes, which are involved in various functions including cell to cell signaling and protein excretion. Here, we have engineered the OMVs of Escherichia coli to nano-scaled bioreactors for the degradation of β-lactam antibiotics. This was exploited by targeting a β-lactamase (i.e., CMY-10) into the OMVs of a hyper-vesiculating E. coli BL21(DE3) mutant. The CMY-10-containing OMVs, prepared from the E. coli mutant cultures, were able to hydrolyze β-lactam ring of nitrocefin and meropenem to a specific rate of 6.6 × 10-8 and 3.9 × 10-12 μmol/min/µm3 of OMV, which is approximately 100 and 600-fold greater than those of E. coli-based whole-cell biocatalsyts. Furthermore, CMY-10, which was encapsulated in the engineered OMVs, was much more stable against temperature and acid stresses, as compared to free enzymes in aqueous phase. The OMV-based nano-scaled reaction system would be useful for the remediation of a variety of antibiotics pollution for food and agricultural industry.

Original languageEnglish
Pages (from-to)1-7
Number of pages7
JournalJournal of Biotechnology
Volume356
DOIs
StatePublished - 10 Sep 2022

Keywords

  • Antibiotics
  • CMY-10
  • Nano-scale bioreactor
  • Outer membrane vesicles

Fingerprint

Dive into the research topics of 'Engineering of a bacterial outer membrane vesicle to a nano-scale reactor for the biodegradation of β-lactam antibiotics'. Together they form a unique fingerprint.

Cite this